Lindsey Trickett | Vice President-Investor Relations |
John Hayes | Controller |
John Leonard | Chief Executive Officer |
Andrew Schiermeier | Executive Vice President, Corporate Strategy |
Maury Raycroft | Jefferies, LLC |
Gena Wang | Barclays |
Martin Auster | Credit Suisse |
Steven Seedhouse | Raymond James |
Good morning my name is Mary. And I will be your conference operator today. At this time, I would like to welcome everyone to the Intellia Therapeutics’ Third Quarter 2018 Earnings and Corporate Developments Conference Call. Today’s conference is being recorded. [Operator Instructions] Thank you Ms.